Levita Magnetics announced the international launch of its MARS surgical system at Hospital Luis Tisne in Santiago, Chile. This marks another milestone in the global advancement of minimally invasive surgery. Dr Julio Jimenez at the Hospital Luis Tisne performed a series of procedures, including same-day discharge cholecystectomy and bariatric surgeries. This deployment of the MARS system comes shortly after the company's first commercial use cases in the US at the world-renowned Cleveland Clinic.
MARS is an FDA-approved, surgical platform that harnesses the power of magnets and machines to reduce incisions, improve visualisation and make laparoscopic surgery more efficient. The MARS system actively transforms high-volume abdominal surgeries, including bariatric surgeries, cholecystectomy, prostate and colorectal procedures, resulting in an improved patient and surgeon experience: reduced pain, faster recovery, and less scarring.
"The deployment of the MARS surgical system in Hospital Luis Tisne, an important public hospital in Santiago, Chile, marks a moment of pride for our entire team. As a surgeon who worked previously for many years in a public hospital in Santiago, today is a watershed moment for the field of minimally invasive surgery, the people of Chile and the global surgical community," said Dr. Alberto Rodriguez-Navarro, surgeon, founder, and CEO of Levita Magnetics. "We are showcasing the rapid adoption of our cutting-edge technology and demonstrating international success. We will continue to push paradigm-shifting solutions across medicine in the coming months through our clinically valuable, cost and space-efficient surgical system."
MARS builds on the clinical benefits of the Levita Magnetic Surgical System with dual surgeon-controlled arms that provide the physician full control over the laparoscopic view and the proprietary Dynamic Magnetic Positioning technology, reducing the need for an additional assistant. The console-free system with a compact footprint benefits hospitals and ambulatory surgical centres through clinical benefit, increased efficiency, more effective deployment of personnel and the ability to offer a differentiated patient experience.
According to the company Levita remains the sole company that holds an FDA-cleared medical device leveraging the power of magnets to reduce incisions and makes surgery less invasive, delivering a triple impact that benefits patients, surgeons and hospitals alike.